Table 1.
Parameter | Antioxidation | Anti-AGEs Formation | Antihyperglycemic | Antihyper-Lipidemia | Antihyper-Tension | ||||
---|---|---|---|---|---|---|---|---|---|
1/IC50, DPPH | 1/IC50, ABTS | Reducing Power | NBT Reduction | Girard-T Assay | 1/IC50, amy | 1/IC50, glu | 1/IC50, PL | 1/IC50, ACE | |
TPC | 0.993 | 0.925 | 0.975 | −0.346 | 0.804 | - | 0.945 | 0.945 | 0.983 |
TFC | 0.907 | 0.829 | 0.794 | 0.042 | 0.585 | - | 0.650 | 0.813 | 0.926 |
1/IC50, DPPH | 1 | 0.953 | 0.944 | −0.337 | 0.735 | - | 0.919 | 0.910 | 0.978 |
1/IC50, ABTS | 1 | 0.828 | −0.522 | 0.530 | - | 0.949 | 0.750 | 0.870 | |
Reducing power | 1 | −0.311 | 0.914 | - | 0.977 | 0.985 | 0.965 | ||
NBT reduction | 1 | −0.121 | - | −0.797 | −0.146 | −0.170 | |||
Girard-T assay | 1 | - | 1.000 | 0.943 | 0.823 | ||||
1/IC50, amy | 1 | - | - | - | |||||
1/IC50, glu | 1 | 0.847 | 0.686 | ||||||
1/IC50, PL | 1 | 0.965 | |||||||
1/IC50, ACE | 1 |